For more information, please click here
SHL Telemedicine completed the acquisition of an additional 27.5% of the shares in Mediton and the remaining 30% of the shares in Medishur
Earlier from Shl Telemedicine
- SHL Telemedicine: announces invitation to a Special General Meeting and proposes “opting-out” from mandatory tender offer obligation
- SHL Telemedicine: receives District Court judgment in Israel regarding remaining 30% stake in Mediton and Medishur
- SHL Telemedicine: announces 2026 Annual General Meeting Results
- SHL Telemedicine: announces full-year 2025 results